« Back to Record
Citation APA

Di Cosimo, S., Appierto, V., Pizzamiglio, S., Tiberio, P., Iorio, M. V., Hilbers, F. F., de Azambuja, E., de la Peña, L., Izquierdo, M., Huober, J., Baselga, J., Piccart-Gebhart, M., De Braud, F. D., Apolone, G., Verderio, P., & Daidone, M. G. (2019). Plasma miRNA levels for predicting therapeutic response to neoadjuvant treatment in HER2-positive breast cancer: Results from the NeoALTTO trial. Clinical cancer research, 25(13), 3887-3895. doi:10.1158/1078-0432.CCR-18-2507


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/291260

Di Cosimo, S., Appierto, V., Pizzamiglio, S., Tiberio, P., Iorio, M. V., Hilbers, F. F., de Azambuja, E., de la Peña, L., Izquierdo, M., Huober, J., Baselga, J., Piccart-Gebhart, M., De Braud, F. D., Apolone, G., Verderio, P., & Daidone, M. G. (2019). Plasma miRNA levels for predicting therapeutic response to neoadjuvant treatment in HER2-positive breast cancer: Results from the NeoALTTO trial. Clinical cancer research, 25(13), 3887-3895. doi:10.1158/1078-0432.CCR-18-2507